Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sleep abnormality in neuromyelitis optica spectrum disorder.
Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Aquaporin-4 autoimmunity.
Diagnostic tools for evaluating the impact of Focal Axonal Swellings arising in neurodegenerative diseases and/or traumatic brain injury.
Cognitive Impairment in Multiple Sclerosis: A Forgotten Disability Remembered.
Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic.
What is the relevance of quality of life assessment for patients with attention impairment?
Living with the unexplained: Coping, distress, and depression among women with chronic fatigue syndrome (CFS) and/or fibromyalgia comparedto an autoimmune disorder.
18F-DOPA, a Clinically Available PET Tracer to Study Brain Inflammation?
Novartis: CHMP Issues Positive Opinion To Expand EU Label For Gilenya In RRMS
I-BET151 selectively regulates IL-6 production.
How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis?
Statins in neurological disorders: An overview and update.
Microanatomy and histological features of central myelin in the root exit zone of facial nerve.
Contribution of symptom clusters to multiple sclerosis consequences.
Whole-body in vivo monitoring of inflammatory diseases exploiting human interleukin 6-luciferase transgenic mice.
Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Proteinticle Engineering for Accurate 3D Diagnosis.
[Biomarkers in multiple sclerosis (a review and experimental data)].
The influence of executive functions and memory on self-generation benefit in persons with multiple sclerosis.
Preliminary validation study of the Spanish version of the satisfaction with life scale in persons with multiple sclerosis.
Pituitary apoplexy presented with optic neuritis.
Exploring Physical Activity in Women with Multiple Sclerosis: Associations with Fear of Falling and Underlying Impairments.
Neurological perspectives on voltage-gated sodium channels.
Pages
« first
‹ previous
…
454
455
456
457
458
459
460
461
462
…
next ›
last »